Furthermore, a cross-sectional study including 117 non-demented individuals carrying gene mutations related to the autosomal dominant-inherited AD (APP, PSEN1 and PSEN2), demonstrated that a greater burden of neuropsychiatric symptoms, as assessed by NPI-Q, was related to increased amyloid pathology in amyloid PET [52]. Here, APP is linked to Alzheimer disease.